UPSP 2011.03.10 (ICE), VetAgro Sup (Université de Lyon), Marcy l'étoile, France.
PLoS One. 2013 Aug 20;8(8):e71547. doi: 10.1371/journal.pone.0071547. eCollection 2013.
This study evaluates a new synthetic substitute (CRYO3, Ref. 5617, Stem Alpha, France) for animal-based products in rabbit embryo cryopreservation solutions. This evaluation was performed using two approaches: a thermodynamic approach using differential scanning calorimetry and a biological approach using rabbit embryo slow-freezing. During the experiment, foetal calf serum (FCS) was used as a reference. Because FCS varies widely by supplier, three different FCS were selected for the thermodynamic approach. The rabbit embryo slow-freezing solutions were made from Dulbecco's phosphate buffer saline containing 1.5 M Dimethyl Sulfoxide and 18% (v.v(-1)) of CRYO3 or 18% (v.v(-1)) of FCS. These solutions were evaluated using four characteristics: the end of melting temperature, the enthalpy of crystallisation (thermodynamic approach) and the embryo survival rates after culture and embryo transfer (biological approach). In the thermodynamic approach, the solutions containing one of the three different FCS had similar mean thermodynamic characteristics but had different variabilities in the overall data with aberrant values. The solution containing CRYO3 had similar thermodynamic properties when compared to those containing FCS. Moreover, no aberrant value was measured in the solution containing CRYO3. This solution appears to be more stable than the solutions containing a FCS. In the biological approach, the in vitro embryo survival rates obtained with the solution containing CRYO3 (73.7% and 81.3%) and with the solution containing a FCS (77.6% and 71.9%) were similar (p = 0.7). Nevertheless, during the in vivo evaluation, the implantation rate (21.8%) and the live-foetuses rate (18.8%) of the CRYO3 group were significantly higher than the implantation rate (7.1%, p = 0.0002) and the live-foetuses rate (5.3%, p = 0.0002) of the FCS group. The pregnancy rate was also higher in the CRYO3 group compared to the FCS group (81.3% and 43.8%, respectively, p = 0.066). We conclude that CRYO3 can be used as a chemically defined substitute for animal-based products in rabbit embryo cryopreservation solutions.
本研究评估了一种新型的合成替代品(CRYO3,Ref.5617,Stem Alpha,法国),用于兔胚胎冷冻保存液中的动物源性产品。这项评估采用了两种方法:热力学方法(差示扫描量热法)和生物学方法(兔胚胎慢速冷冻)。在实验中,胎牛血清(FCS)被用作参考。由于 FCS 供应商差异很大,因此为热力学方法选择了三种不同的 FCS。兔胚胎慢速冷冻保存液由含有 1.5 M 二甲基亚砜和 18%(v.v(-1))的 CRYO3 或 18%(v.v(-1))的 FCS 的 Dulbecco's 磷酸盐缓冲液制成。这些溶液使用四个特征进行评估:融化终点温度、结晶焓(热力学方法)和培养后胚胎存活率和胚胎移植(生物学方法)。在热力学方法中,含有三种不同 FCS 之一的溶液具有相似的平均热力学特性,但在整个数据中具有不同的可变性,并且存在异常值。与含有 FCS 的溶液相比,含有 CRYO3 的溶液具有相似的热力学性质。此外,在含有 CRYO3 的溶液中未测量到异常值。该溶液似乎比含有 FCS 的溶液更稳定。在生物学方法中,含有 CRYO3 的溶液(73.7%和 81.3%)和含有 FCS 的溶液(77.6%和 71.9%)的体外胚胎存活率相似(p=0.7)。然而,在体内评估中,CRYO3 组的着床率(21.8%)和活胎率(18.8%)显著高于 FCS 组的着床率(7.1%,p=0.0002)和活胎率(5.3%,p=0.0002)。与 FCS 组相比,CRYO3 组的妊娠率也更高(分别为 81.3%和 43.8%,p=0.066)。我们得出结论,CRYO3 可作为兔胚胎冷冻保存液中动物源性产品的化学定义替代品。